Marion McCourt - May 7, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Commercial
Signature
/s/**Marion McCourt
Stock symbol
REGN
Transactions as of
May 7, 2021
Transactions value $
-$152,700
Form type
4
Date filed
5/10/2021, 04:02 PM
Next filing
Jun 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $343K +1K +5.87% $342.93 18K May 7, 2021 Direct
transaction REGN Common Stock Sale -$496K -1K -5.54% $495.63 17K May 7, 2021 Direct F1
holding REGN Common Stock 108 May 7, 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1K -5.56% $0.00 17K May 7, 2021 Common Stock 1K $342.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 1,000 shares of Company stock on May 7, 2021 at prices ranging from $495.47 to $495.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2021 at each separate price.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.